[1] |
Caroni P, Schwab ME. Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading[J]. J Cell Biol, 1988,106(4):1281-1288.
|
[2] |
Spillmann AA. Lottspeich, F. Identification and characterization of a bovine neurite growth inhibitor (bNI-220)[J]. J Biol Chem, 1998, 273(30):19283-19293.
|
[3] |
Chen MS, Huber AB, van der Haar ME, et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1[J]. Nature, 2000, 403(6768):434-439.
|
[4] |
GrandPre T, Nakamura F, Vartanian T, et al. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein[J]. Nature, 2000, 403(6768):439-444.
|
[5] |
Dodd DA, Niederoest B, Bloechlinger S, et al. Nogo-A, -B, and -C are found on the cell surface and interact together in many different cell types[J]. J Biol Chem, 2005,280(13):12494-12502.
|
[6] |
Huber AB, Weinmann O, Brosamle C, et al. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions[J]. J Neurosci, 2002,22(9):3553-3567.
|
[7] |
Pot C, Simonen M, Weinmann O, et al. Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury[J]. J Cell Biol, 2002, 159(1):29-35.
|
[8] |
Petrinovic MM, Duncan CS, Bourikas D, et al. Neuronal Nogo-A regulates neurite fasciculation, branching and extension in the developing nervous system[J]. Development, 2010, 137(15):2539-2550.
|
[9] |
Ahmed Z, Suggate EL, Brown ER, et al. Schwann cell-derived factor-induced modulation of the NgR/p75NTR/EGFR axis disinhibits axon growth through CNS myelin in vivo and in vitro[J]. Brain, 2006, 129(Pt 6):1517-1533.
|
[10] |
Wong ST, Henley JR, Kanning KC, et al. A p75(NTR)and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein[J]. Nat Neurosci, 2002, 5(12):1302-1308.
|
[11] |
Park JB, Yiu G, Kaneko S, et al. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors[J]. Neuron, 2005, 45(3):345-351.
|
[12] |
Fournier AE, GrandPre T, Strittmatter SM. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration[J]. Nature, 2001, 409(6818):341-346.
|
[13] |
Oertle T, Schwab ME. Nogo and its paRTNers[J]. Trends Cell Biol, 2003, 13(4):187-194.
|
[14] |
Miao RQ, Gao Y, Harrison KD, et al. Identification of a receptor necessary for Nogo-B stimulated chemotaxis and morphogenesis of endothelial cells[J]. Proc Natl Acad Sci U S A, 2006, 103(29):10997-11002.
|
[15] |
Schweigreiter R, Stasyk T, Contarini I, et al. Phosphorylation-regulated cleavage of the reticulon protein Nogo-B by caspase-7 at a noncanonical recognition site[J]. Proteomics, 2007, 7(24):4457-4467.
|
[16] |
Eckharter C, Junker N, Winter L, et al. Schwann Cell Expressed Nogo-B Modulates Axonal Branching of Adult Sensory Neurons Through the Nogo-B Receptor NgBR[J]. Front Cell Neurosci, 2015, 9(454).
|
[17] |
Weng L, Jia S, Xu C, et al. Nogo-C regulates post myocardial infarction fibrosis through the interaction with ER Ca2+ leakage channel Sec61alpha in mouse hearts[J]. Cell Death Dis, 2018, 9(6):612.
|
[18] |
Kim JE, Bonilla IE, Qiu D, et al. Nogo-C is sufficient to delay nerve regeneration[J]. Mol Cell Neurosci, 2003, 23(3):451-459.
|
[19] |
Venkatesh K, Chivatakarn O, Lee H, et al. The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein[J]. J Neurosci, 2005, 25(4):808-822.
|
[20] |
McKerracher L, David S. Easing the brakes on spinal cord repair[J]. Nat Med, 2004, 10(10):1052-1053.
|
[21] |
Fry EJ, Ho C, David S. A role for Nogo receptor in macrophage clearance from injured peripheral nerve[J]. Neuron, 2007, 53(5):649-662.
|
[22] |
Kuhlmann T, Bitsch A, Stadelmann C, et al. Macrophages are eliminated from the injured peripheral nerve via local apoptosis and circulation to regional lymph nodes and the spleen[J]. J Neurosci, 2001, 21(10):3401-3408.
|
[23] |
David S, Fry EJ, Lopez-Vales R. Novel roles for Nogo receptor in inflammation and disease[J]. Trends Neurosci, 2008, 31(5):221-226.
|